BMP5 and colorectal carcinoma: TCGA data showed BMP5 was significantly downregulated in CRC (Wilcoxon test, P = 7.797e− 28) (Fig. 2c), and early stage (Stage I) patients showed higher expression than other stage patients (unpaired t test, P < 0.05).